← Leaderboards
Gang Bao
Georgia Institute Of Technology
$62,962,213
Attributed
$67,728,250
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,728,250 · 15
By mechanism
PN2$24,361,796 · 1
N01$14,615,641 · 1
U01$10,989,648 · 1
R01$10,122,173 · 5
UG3$2,297,149 · 1
R42$1,654,761 · 1
Top collaborators
- Gregory C. Gibson5 shared
- Junghae Suh5 shared
- Konstantin V Sokolov4 shared
- William Raymond Lagor3 shared
- Caleb Bashor1 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Gregory C. Gibson$7,991,905
- Harold D Kim$2,621,040
- James Dahlman$4,346,621
- Todd C McDevitt$8,030,444
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseGenesSiteDesignComplexProteinsNovel StrategiesNanotechnologyAffectBiologicalAllelesMalignant NeoplasmsCrispr/Cas TechnologySignal TransductionEnzymesEngineeringGenome EditingMutationGuide RnaDna RepairModificationGeneticIn Vivo
Grant awards (53)
Precision mapping of regulatory causal variants by expression CROPseq$682,310
R01 · FY2025 · HG
Deciphering unintended large gene modifications in gene editing for sickle cell disease$642,458
R01 · FY2025 · HL · contact PI
Engineering BV to efficiently deliver large genetic payloads$413,182
R21 · FY2025 · EB
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$358,828
T32 · FY2025 · CA
Precision mapping of regulatory causal variants by expression CROPseq$682,624
R01 · FY2024 · HG
Deciphering unintended large gene modifications in gene editing for sickle cell disease$632,319
R01 · FY2024 · HL · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$116,023
T32 · FY2024 · CA
Deciphering unintended large gene modifications in gene editing for sickle cell disease$78,410
R01 · FY2024 · HL · contact PI
Deciphering unintended large gene modifications in gene editing for sickle cell disease$42,336
R01 · FY2024 · HL · contact PI
Precision mapping of regulatory causal variants by expression CROPseq$696,862
R01 · FY2023 · HG
Deciphering unintended large gene modifications in gene editing for sickle cell disease$662,035
R01 · FY2023 · HL · contact PI
HBB gene-editing for treating sickle cell disease$605,943
R01 · FY2023 · HL · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$533,133
T32 · FY2023 · CA
Precision mapping of regulatory causal variants by expression CROPseq$697,161
R01 · FY2022 · HG
HBB gene-editing for treating sickle cell disease$609,071
R01 · FY2022 · HL · contact PI
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology$205,642
T32 · FY2022 · CA
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$762,524
UG3 · FY2021 · HL · contact PI
Precision mapping of regulatory causal variants by expression CROPseq$710,460
R01 · FY2021 · HG
HBB gene-editing for treating sickle cell disease$612,108
R01 · FY2021 · HL · contact PI
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$467,852
R01 · FY2021 · HL · contact PI
Addressing safety issues by quantify large deletions and chromosomal rearrangements in HBB gene editing$1,173,874
OT2 · FY2020 · HL · contact PI
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$758,237
UG3 · FY2020 · HL · contact PI
HBB gene-editing for treating sickle cell disease$629,375
R01 · FY2020 · HL · contact PI
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$473,855
R01 · FY2020 · HL · contact PI
Provectors for treatment of ovarian cancer$352,623
R01 · FY2020 · CA · contact PI
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity$776,388
UG3 · FY2019 · HL · contact PI
Targeted Gene Therapy of Heart Failure Post Myocardial Infarction$502,327
R01 · FY2019 · HL · contact PI
Provectors for treatment of ovarian cancer$342,044
R01 · FY2019 · CA · contact PI
Nanomedicine Center for Nucleoprotein Machines$30,001
PN2 · FY2015 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$2,537,849
PN2 · FY2014 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$662,151
PN2 · FY2014 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$3,224,999
PN2 · FY2013 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$3,224,999
PN2 · FY2012 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$3,100,000
PN2 · FY2011 · EY · contact PI
TAS::75 0872::TAS CENTER FOR TRANSLATIONAL CARDIOVASCULAR NANOMEDICINE$14,615,641
N01 · FY2010 · HL · contact PI
Nanomedicine Center for Nucleoprotein Machines$3,054,463
PN2 · FY2010 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$2,880,001
PN2 · FY2009 · EY · contact PI
Nanotechnology: Detection & Analysis of Plaque Formation$2,387,911
U01 · FY2009 · HL · contact PI
Molecular Beacons and Activatable Probes for Cancer Detection and Analysis$455,230
U54 · FY2009 · CA · contact PI
Nanomedicine Center for Nucleoprotein Machines$2,410,001
PN2 · FY2008 · EY · contact PI
Nanotechnology: Detection & Analysis of Plaque Formation$2,264,225
U01 · FY2008 · HL · contact PI
Molecular Beacons and Activatable Probes for Cancer Detection and Analysis$345,789
U54 · FY2008 · CA · contact PI
Nanotechnology: Detection & Analysis of Plaque Formation$2,235,939
U01 · FY2007 · HL · contact PI
Nanomedicine Center for Nucleoprotein Machines$1,472,002
PN2 · FY2007 · EY · contact PI
In vivo gene detection for cancer analysis$690,743
R42 · FY2007 · CA · contact PI
Nanomedicine Center for Nucleoprotein Machines$227,446
PN2 · FY2007 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$200,000
PN2 · FY2007 · EY · contact PI
Nanomedicine Center for Nucleoprotein Machines$150,300
PN2 · FY2007 · EY · contact PI
Nanotechnology: Detection & Analysis of Plaque Formation$2,563,630
U01 · FY2006 · HL · contact PI
Nanomedicine Center for Nucleoprotein Machines$1,187,584
PN2 · FY2006 · EY · contact PI
In vivo gene detection for cancer analysis$964,018
R42 · FY2006 · CA · contact PI
Nanotechnology: Detection &Analysis of Plaque Formation$1,537,943
U01 · FY2005 · HL
Nanomachines for RNA Synthesis and DNA Repair (RMI)$85,381
PN1 · FY2004 · EY